Improving anti-melanoma effect of curcumin by biodegradable nanoparticles

This publication has 44 references indexed in Scilit:

• Prognosis of Mucosal, Uveal, Acral, Nonacral Cutaneous, and Unknown Primary Melanoma From the Time of First Metastasis
  The Oncologist, 2016
• Cancer statistics in China, 2015
  CA: A Cancer Journal for Clinicians, 2016
• Cancer statistics, 2016
  CA: A Cancer Journal for Clinicians, 2016
• Survival of patients with advanced metastatic melanoma: The impact of novel therapies
  European Journal of Cancer, 2016
• Checkpoint blockade for cancer therapy: revitalizing a suppressed immune system
  Trends in Molecular Medicine, 2015
• Nivolumab versus chemotherapy in patients with advanced melanoma who progressed after anti-CTLA-4 treatment (CheckMate 037): a randomised, controlled, open-label, phase 3 trial
  The Lancet Oncology, 2015
• PD-1 pathway inhibitors: The next generation of immunotherapy for advanced melanoma
  Oncotarget, 2015
• Immunotherapy of melanoma: Present options and future promises
  Cancer and Metastasis Reviews, 2015
• Clinical Impact of Checkpoint Inhibitors as Novel Cancer Therapies
  Drugs, 2014
• Ipilimumab plus Dacarbazine for Previously Untreated Metastatic Melanoma
  New England Journal of Medicine, 2011